Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview

SIMPLE SUMMARY: The use of tyrosine kinase inhibitors has significantly improved the outcome of patients with ALK (anaplastic lymphoma kinase)-rearranged non-small cell lung cancer. Combining drugs with radiotherapy could increase its effectiveness on tumors or overcome resistance to ALK-targeted th...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoni, Delphine, Burckel, Hélène, Noel, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156706/
https://www.ncbi.nlm.nih.gov/pubmed/34063424
http://dx.doi.org/10.3390/cancers13102394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156706/
https://www.ncbi.nlm.nih.gov/pubmed/34063424
http://dx.doi.org/10.3390/cancers13102394

Ejemplares similares